Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Advarra announced the launch of the Council for Responsible Use of AI in Clinical Trials. The Council, which includes leaders from across the life sciences industry, will focus on setting standards, strengthening model governance, and defining ...
read more
Tuesday, January 29, 2019
Hovione has issued a bond of $50 million US dollars maturing in 2033.
read more
Wednesday, March 03, 2021
Recipharm has announced its 2020 International Environmental Award will be presented to Dr. Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia.
read more
QPharma, a leader in Medical, Commercial and Compliance Services for the life sciences industry is proud to announce the launch of Neolytica, a subsidiary, that will take healthcare analytics to an entirely new level.
read more
Wednesday, February 11, 2015
A new white paper released today by Exel, the North American leader in contract logistics, in conjunction with its sister company DHL Supply Chain, the world’s leading logistics company, has revealed that theft, pharmaceutical counterfeiting, ...
read more
Tuesday, September 22, 2020
Aphena Pharma Solutions has announced a $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, with the acquisition of a 500,000-square-foot property, purpose-built for FDA manufacturing and packaging operations.
read more
Tuesday, January 28, 2014
Almac’s Diagnostics business unit today announced the publication of its breast cancer chemotherapy response assay in the Journal of the National Cancer Institute (JNCI).
read more
BioDuro, LLC, a global contract research organization (CRO) focused on fully outsourced turnkey discovery and development services in Oncology, Inflammatory Disease, Metabolism and CNS for pharmaceutical partners, has announced the formal launch of ...
read more
Wednesday, October 26, 2022
QSAM Biosciences, Inc. announced the addition of Rutgers Cancer Institute of New Jersey (RCINJ) as a clinical trial site approved to begin enrolling patients into the Phase 1 study evaluating CycloSam® in treating patients with bone cancer that ...
read more
Monday, September 09, 2024
Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The additional space will significantly increase manufacturing capacity, strengthen the current Symbiosis commercial manufacturing service ...
read more
PCI has announced further investment to expand its flagship manufacturing center in Tredegar, Wales.
read more
Tuesday, October 06, 2015
Nuventra has announced that David Y. Mitchell, Ph.D. will serve as the company’s new Chief Scientific Officer (CSO).
read more
Wednesday, March 02, 2016
Xpertdoc Technologies Inc., a Microsoft Gold Partner and a document generation and customer communications solutions provider, has announced that Camargo Pharmaceutical Services has selected Xpertdoc’s CCM platform and Microsoft Dynamics CRM ...
read more
Thursday, January 29, 2026
Vetter has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany.
read more
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a De Novo approval by the FDA for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new...
read more